01:30 PM BST, United States - GDP data:
- GDP (Q3): actual 4.3% QoQ; forecast 3.3% QoQ; previous 3.8% QoQ;
- GDP Price Index (Q3): actual 3.7% QoQ; forecast 2.7% QoQ; previous 2.1% QoQ;
- PCE Prices (Q3): actual 2.8%; forecast 2.9%; previous 2.1%;
- Core PCE Prices (Q3): actual 2.90%; forecast 2.90%; previous 2.60%;
- GDP Sales (Q3): actual 4.6%; previous 7.5%;
- Real Consumer Spending (Q3): actual 3.5%; previous 2.5%;
U.S. real GDP grew at a strong 4.3% annualized rate in Q3 2025, accelerating from 3.8% in Q2, driven by faster consumer spending alongside rebounds in exports and government spending, while investment declined and imports fell. Inflation pressures firmed, with the PCE price index rising 2.8% (core 2.9%), up from Q2, and the gross domestic purchases price index increasing 3.4%. Real final sales to private domestic purchasers edged up to 3.0%, real GDI rose a more modest 2.4%, and corporate profits surged by $166.1bn, marking a sharp improvement from the prior quarter.
01:30 PM BST, United States - Durable Goods for October:
- Durable Goods Orders: actual -2.2% MoM; forecast -1.5% MoM; previous 0.7% MoM;
- Core Durable Goods Orders: actual 0.2% MoM; forecast 0.3% MoM; previous 0.7% MoM;
- Durables Excluding Defense: actual -1.5% MoM; previous 0.1% MoM;
- Durables Excluding Transport: forecast 0.3% MoM; previous 0.6% MoM;
U.S. durable goods orders fell 2.2% m/m in October to $307.4bn, snapping two months of gains, largely due to a 6.5% drop in transportation equipment orders, which subtracted $7.2bn. Underlying demand was more resilient, however, with orders excluding transportation up 0.2%, while core orders excluding defense declined 1.5%, pointing to softer headline momentum but a less severe slowdown beneath the surface.
Novo Nordisk - There Were Risks, Now It's Time for Opportunities.
BREAKING: CB consumer sentiment bellow expectations!๐ฅ๐
BREAKING: US industry data slightly better than expected!๐ญ๐
Chart of the day: GOLD (23.12.2025)
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.